|
1
|
Weitz J, Koch M, Debus J, Höhler T, Galle
PR and Büchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lindblom A, Zhou XL, Liu T, Liljegren A,
Skoglund J, Djureinovic T and Swedish Low-Risk; Colorectal Cancer
Group: Colorectal cancer as a complex disease: Defining at-risk
subjects in the general population - a preventive strategy. Expert
Rev Anticancer Ther. 4:377–385. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zauber AG, Lansdorp-Vogelaar I, Knudsen
AB, Wilschut J, van Ballegooijen M and Kuntz KM: Evaluating test
strategies for colorectal cancer screening: A decision analysis for
the U.S. Preventive Services Task Force. Ann Intern Med.
149:659–669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lambert R, Sauvaget C and Sankaranarayanan
R: Mass screening for colorectal cancer is not justified in most
developing countries. Int J Cancer. 125:253–256. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu AG, Yu ZJ, Jiang B, Wang XY, Zhong XH,
Liu JH, Lou QY and Gan AH: Colorectal cancer in Guangdong Province
of China: A demographic and anatomic survey. World J Gastroenterol.
16:960–965. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Folkesson J, Martling A and Kodeda K:
Current considerations in colorectal cancer surgery. Colorectal
Cancer. 4:167–174. 2015. View Article : Google Scholar
|
|
9
|
Gustavsson B, Carlsson G, Machover D,
Petrelli N, Roth A, Schmoll HJ, Tveit KM and Gibson F: A review of
the evolution of systemic chemotherapy in the management of
colorectal cancer. Clin Colorectal Cancer. 14:1–10. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dagoglu N, Mahadevan A, Nedea E, Poylin V
and Nagle D: Stereotactic body radiotherapy (SBRT) reirradiation
for pelvic recurrence from colorectal cancer. J Surg Oncol.
111:478–482. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marin JJ, Sanchez de Medina F, Castaño B,
Bujanda L, Romero MR, Martinez-Augustin O, Moral-Avila RD and Briz
O: Chemoprevention, chemotherapy, and chemoresistance in colorectal
cancer. Drug Metab Rev. 44:148–172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yin SY, Wei WC, Jian FY and Yang NS:
Therapeutic applications of herbal medicines for cancer patients.
Evid Based Complement Alternat Med. 2013:3024262013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao M, Lau ST, Leung PS, Che CT and Lin
ZX: Seven quassinoids from Fructus Bruceae with cytotoxic effects
on pancreatic adenocarcinoma cell lines. Phytother Res.
25:1796–1800. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Commission CP: Pharmacopoeia of People's
Republic of China. 1. Chinese Medical Science and Technology Press;
Beijing: pp. 174–175. 2010
|
|
15
|
Fukamiya N, Okano M, Miyamoto M, Tagahara
K and Lee KH: Antitumor agents, 127. Bruceoside C, a new cytotoxic
quassinoid glucoside, and related compounds fro. Brucea javanica J
Nat Prod. 55:468–475. 1992. View Article : Google Scholar
|
|
16
|
Turpaev K and Welsh N: Brusatol inhibits
the response of cultured beta-cells to pro-inflammatory cytokines
in vitro. Biochem Biophys Res Commun. 460:868–872. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Allen D, Toth I, Wright C, Kirby G,
Warhurst D and Phillipson J: In vitro antimalarial and cytotoxic
activities of semisynthetic derivatives of brusatol. Eur J Med
Chem. 28:265–269. 1993. View Article : Google Scholar
|
|
18
|
Cuendet M, Gills JJ and Pezzuto JM:
Brusatol-induced HL-60 cell differentiation involves NF-kappaB
activation. Cancer Lett. 206:43–50. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hitotsuyanagi Y, Kim IH, Hasuda T,
Yamauchi Y and Takeya K: A structure-activity relationship study of
brusatol, an antitumor quassinoid. Tetrahedron. 62:4262–4271. 2006.
View Article : Google Scholar
|
|
20
|
Mata-Greenwood E, Cuendet M, Sher D,
Gustin D, Stock W and Pezzuto JM: Brusatol-mediated induction of
leukemic cell differentiation and G(1) arrest is associated with
downregulation of c-myc. Leukemia. 16:2275–2284. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren D, Villeneuve NF, Jiang T, Wu T, Lau
A, Toppin HA and Zhang DD: Brusatol enhances the efficacy of
chemotherapy by inhibiting the Nrf2-mediated defense mechanism.
Proc Natl Acad Sci USA. 108:1433–1438. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Olayanju A, Copple IM, Bryan HK, Edge GT,
Sison RL, Wong MW, Lai ZQ, Lin ZX, Dunn K, Sanderson CM, et al:
Brusatol provokes a rapid and transient inhibition of Nrf2
signaling and sensitizes mammalian cells to chemical
toxicity-implications for therapeutic targeting of Nrf2. Free Radic
Biol Med. 78:202–212. 2015. View Article : Google Scholar :
|
|
23
|
Chou TC and Talalay P: Analysis of
combined drug effects: A new look at a very old problem. Trends
Pharmacol Sci. 4:450–454. 1983. View Article : Google Scholar
|
|
24
|
Ashton JC: Drug combination studies and
their synergy quantification using the Chou-Talalay method -
letter. Cancer Res. 75:2400. 2015. View Article : Google Scholar
|
|
25
|
Florea AM and Büsselberg D: Cisplatin as
an antitumor drug: Cellular mechanisms of activity, drug resistance
and induced side effects. Cancers (Basel). 3:1351–1371. 2011.
View Article : Google Scholar
|
|
26
|
Li B, Gao Y, Rankin GO, Rojanasakul Y,
Cutler SJ, Tu Y and Chen YC: Chaetoglobosin K induces apoptosis and
G2 cell cycle arrest through p53-dependent pathway in
cisplatin-resistant ovarian cancer cells. Cancer Lett. 356:418–433.
2015. View Article : Google Scholar :
|
|
27
|
Galluzzi L, López-Soto A, Kumar S and
Kroemer G: Caspases connect cell-death signaling to organismal
homeostasis. Immunity. 44:221–231. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin Y, Yang X, Lu M, Zheng W, Zhang J,
Zhuang H and Hua ZC: Herbal compound triptolide synergistically
enhanced antitumor activity of vasostatin 120–180. Anticancer
Drugs. 24:945–957. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cao W, Li XQ, Wang X, Fan HT, Zhang XN,
Hou Y, Liu SB and Mei QB: A novel polysaccharide, isolated from
Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical
cancer HeLa cells through an intrinsic apoptotic pathway.
Phytomedicine. 17:598–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kroemer G and Reed JC: Mitochondrial
control of cell death. Nat Med. 6:513–519. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Doonan F and Cotter TG: Morphological
assessment of apoptosis. Methods. 44:200–204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: A basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fadok VA1, de Cathelineau A, Daleke DL,
Henson PM and Bratton DL: Loss of phospholipid asymmetry and
surface exposure of phosphatidylserine is required for phagocytosis
of apoptotic cells by macrophages and fibroblasts. J Biol Chem.
276:1071–1077. 2001. View Article : Google Scholar
|
|
34
|
Vermes I, Haanen C, Steffens-Nakken H and
Reutelingsperger C: A novel assay for apoptosis. Flow cytometric
detection of phosphatidylserine expression on early apoptotic cells
using fluorescein labelled Annexin V. J Immunol Methods. 184:39–51.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
van Engeland M, Nieland LJ, Ramaekers FC,
Schutte B and Reutelingsperger CP: Annexin V-affinity assay: A
review on an apoptosis detection system based on phosphatidylserine
exposure. Cytometry. 31:1–9. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Budihardjo I, Oliver H, Lutter M, Luo X
and Wang X: Biochemical pathways of caspase activation during
apoptosis. Annu Rev Cell Dev Biol. 15:269–290. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ashkenazi A and Dixit VM: Death receptors:
Signaling and modulation. Science. 281:1305–1308. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li P, Nijhawan D, Budihardjo I,
Srinivasula SM, Ahmad M, Alnemri ES, Wang X and Li P1: Cytochrome c
and dATP-dependent formation of Apaf-1/caspase-9 complex initiates
an apoptotic protease cascade. Cell. 91:479–489. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao K, Jin M, Chen Q and Zheng PS:
Polysaccharides produced by Enterobacter cloacae induce apoptosis
in cervical cancer cells. Int J Biol Macromol. 72:960–964. 2015.
View Article : Google Scholar
|
